Symrise Acquires Kaden Biochemicals GmbH

March 6, 2006

1 Min Read
Supply Side Supplement Journal logo in a gray background | Supply Side Supplement Journal


Symrise Acquires Kaden Biochemicals GmbH

HOLZMINDEN, GermanySymrise GmbH & Co. acquired KadenBiochemicals GmbH, expanding its position as a leader in the internationalfragrance, cosmetics and food industries. Kaden Biochemicals is based inHamburg, where it produces active ingredients from plant material. According toSymrise, the acquisition positions the company for further growth in newmarkets. Gerold Linzbach, Ph.D., chief executive officer (CEO) at Symrise(www.symrise.com), said: This acquisition gives us a good position on thehighly attractive market for functional foods and nutraceuticals. As a result, we can now offer a much broader spectrum, and we can presentourselves even more strongly as a source of comprehensive sensory solutions fornearly every challenge on the market.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like